SCHEMBL21726019

SCHEMBL21726019

O=C(OCc1ccccc1)c1ncccc1-c1ccccc1I

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
L3MBTL1 Q9Y468 4/20 0.49
RAB9A P51151 3/20 0.49
TSHR P16473 2/20 0.49
CASP3 P42574 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
TDP1 Q9NUW8 3/20 0.48
LMNA P02545 3/20 0.48
KMT2A Q03164 2/20 0.48
EGLN1 Q9GZT9 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KCNA5 P22460 1/20 0.43
ALDH1A1 P00352 6/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MAOB P27338 1/20 0.43
ADORA2A P29274 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21726023 0.79 ALDH1A1 (0.61) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL19808952 0.79 TDP1 (0.59) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL20201222 0.77 POLB (0.57) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL28566933 0.77 POLB (0.65) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL28041139 0.77 POLB (0.57) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL2835796 0.77 POLB (0.57) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL23996876 0.76 POLB (0.56) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL3515603 0.76 LTA4H (0.49) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL20457001 0.75 POLB (0.62) POLBL3MBTL1RAB9ATSHRCASP3
SCHEMBL22258205 0.74 POLB (0.69) POLBL3MBTL1RAB9ATSHRCASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10566547-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10566547-B2 Organic electroluminescent materials and devices PAX2, EYA2, NLRP1 POLB 3938/4885L3MBTL1 3549/4885RAB9A 1798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.